The Canadian Ministry of Health has completed revisions to the Cannabis Act, which now includes increased restrictions on the possession of cannabis beverages and relaxed requirements for research and testing.
According to an announcement by the Canadian Department of Health on December 9th, the amendment came into effect on December 2nd.
A copy of the final regulation and a statement on regulatory impact and analysis will be published in the second section of the Canada Gazette on December 21.
According to the announcement, the amendment incorporates feedback from stakeholders in the cannabis industry, universities, researchers, health authorities, trade associations, licensees, provinces, regions, and the public.
A new regulation has been implemented to increase public possession restrictions on marijuana drinks in order to align with other marijuana products. Adults are now allowed to possess a maximum of 17.1 liters (equivalent to 48,355 milliliter cans) for non-medical purposes.
Under previous Canadian regulations, adults were allowed to possess approximately 2.1 liters of cannabis beverage or roughly five 355-milliliter cans.
These amendments also aim to simplify marijuana research by altering the requirements for non-therapeutic studies involving human participants.
In addition, the new regulations allow holders of analytical testing licenses as well as federal and provincial government labs to produce, distribute and sell reference standards and testing kits in order to increase access to cannabis testing materials.
The amendment also expands the educational qualification requirements for laboratory directors, who hold a mandatory position in analytical testing laboratories responsible for all cannabis testing activities at the facility.
These latest amendments are part of Canada's ongoing efforts to improve the Cannabis Act, which came into effect in October 2018 and aims to legalize the production, distribution, sale, and possession of cannabis for adults aged 21 and over.
In September, the Canadian government announced that it has initiated a necessary review of the Cannabis Act to assess its impact on the illegal market, indigenous communities, and the economy.
Last month, government officials appointed a five-member expert panel responsible for conducting reviews.
The group will ultimately present recommendations to Health Minister Jean-Yves Duclos and Minister of Mental Health and Addictions and Deputy Minister of Health Carolyn Bennett on progress towards achieving the objectives of the Cannabis Act, which include protecting the health and safety of Canadians, establishing a diverse and competitive legal industry to replace the illegal market, and identifying areas for legal improvement.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
